41例肝炎相关再生障碍性贫血患者临床特征与免疫抑制治疗疗效观察
目的分析肝炎相关再生障性贫血（HAAA）临床特征，评价其免疫抑制治疗（IST）疗效及生存状况。方法回顾性分析944例接受IST的重型／极重型AA（SAANSAA）患者，比较41例HAAA患者与年龄、造血衰竭程度相匹配的123例特发性AA（IAA）临床特征、血液学反应率、长期生存率及克隆性演变情况。结果944例SAA／VSAA患者中HAAA41例（4．34％），HAAA患者中VSAA所占比例明显高于IAA患者（65．9％对39．4％，P=0．001）。HAAA与匹配的IAA比较，患者感染发生率差异无统计学意义，但感染控制所需时间明显延长[21（4～100）d对13（3-139）d，P=0．048...
Saved in:
| Published in | 中华血液学杂志 Vol. 37; no. 5; pp. 399 - 404 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
中国医学科学院、北京协和医学院血液学研究所、血液病医院, 天津,300020
2016
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0253-2727 |
| DOI | 10.3760/cma.j.issn.0253-2727.2016.05.009 |
Cover
Loading…
| Abstract | 目的分析肝炎相关再生障性贫血（HAAA）临床特征，评价其免疫抑制治疗（IST）疗效及生存状况。方法回顾性分析944例接受IST的重型／极重型AA（SAANSAA）患者，比较41例HAAA患者与年龄、造血衰竭程度相匹配的123例特发性AA（IAA）临床特征、血液学反应率、长期生存率及克隆性演变情况。结果944例SAA／VSAA患者中HAAA41例（4．34％），HAAA患者中VSAA所占比例明显高于IAA患者（65．9％对39．4％，P=0．001）。HAAA与匹配的IAA比较，患者感染发生率差异无统计学意义，但感染控制所需时间明显延长[21（4～100）d对13（3-139）d，P=0．048]。HAAA患者CD3＋、CD3＋CD4＋、CD3＋CD8＋T淋巴细胞绝对值及CD4＋／CD8＋细胞比值均明显低于IAA患者，而CD3＋CD8＋T淋巴细胞比例明显高于IAA患者，差异均有统计学意义。HAAA与IAA患者IST后3个月（34．1％对34．1％，P=1．000）、6个月（56．1％对53．7％，P=0．787）及12个月（73．2％对68．3％，P=0．558）血液学反应率差异无统计学意义，两组患者预期5年总生存（OS）率、无事件生存（EFS）率比较差异均无统计学意义（OS率：90．0％对87．1％，P=0．700；EFS率：71．9％对62．4％，P=0．450）。结论HAAA少见，造血衰竭更为严重，感染相对难以控制，采用标准IST方案治疗可获得与IAA患者相当的疗效。 |
|---|---|
| AbstractList | 目的 分析肝炎相关再生障性贫血(HAAA)临床特征,评价其免疫抑制治疗(IST)疗效及生存状况.方法 回顾性分析944例接受IST的重型/极重型AA(SAA/VSAA)患者,比较41例HAAA患者与年龄、造血衰竭程度相匹配的123例特发性AA(IAA)临床特征、血液学反应率、长期生存率及克隆性演变情况.结果 944例SAA/VSAA患者中HAAA41例(4.34％),HAAA患者中VSAA所占比例明显高于IAA患者(65.9％对39.4％,P=0.001).HAAA与匹配的IAA比较,患者感染发生率差异无统计学意义,但感染控制所需时间明显延长[21 (4～100)d对13(3～139)d,P=0.048].HAAA患者CD3+、CD3+CD4+、CD3+CD8+T淋巴细胞绝对值及CD4+/CD8+细胞比值均明显低于IAA患者,而CD3+CD8+T淋巴细胞比例明显高于IAA患者,差异均有统计学意义.HAAA与IAA患者IST后3个月(34.1％对34.1％,P=1.000)、6个月(56.1％对53.7％,P=0.787)及12个月(73.2％对68.3％,P=0.558)血液学反应率差异无统计学意义,两组患者预期5年总生存(OS)率、无事件生存(EFS)率比较差异均无统计学意义(OS率:90.0％对87.1％,P=0.700;EFS率:71.9％对62.4％,P=0.450).结论 HAAA少见,造血衰竭更为严重,感染相对难以控制,采用标准IST方案治疗可获得与IAA患者相当的疗效. 目的分析肝炎相关再生障性贫血（HAAA）临床特征，评价其免疫抑制治疗（IST）疗效及生存状况。方法回顾性分析944例接受IST的重型／极重型AA（SAANSAA）患者，比较41例HAAA患者与年龄、造血衰竭程度相匹配的123例特发性AA（IAA）临床特征、血液学反应率、长期生存率及克隆性演变情况。结果944例SAA／VSAA患者中HAAA41例（4．34％），HAAA患者中VSAA所占比例明显高于IAA患者（65．9％对39．4％，P=0．001）。HAAA与匹配的IAA比较，患者感染发生率差异无统计学意义，但感染控制所需时间明显延长[21（4～100）d对13（3-139）d，P=0．048]。HAAA患者CD3＋、CD3＋CD4＋、CD3＋CD8＋T淋巴细胞绝对值及CD4＋／CD8＋细胞比值均明显低于IAA患者，而CD3＋CD8＋T淋巴细胞比例明显高于IAA患者，差异均有统计学意义。HAAA与IAA患者IST后3个月（34．1％对34．1％，P=1．000）、6个月（56．1％对53．7％，P=0．787）及12个月（73．2％对68．3％，P=0．558）血液学反应率差异无统计学意义，两组患者预期5年总生存（OS）率、无事件生存（EFS）率比较差异均无统计学意义（OS率：90．0％对87．1％，P=0．700；EFS率：71．9％对62．4％，P=0．450）。结论HAAA少见，造血衰竭更为严重，感染相对难以控制，采用标准IST方案治疗可获得与IAA患者相当的疗效。 |
| Abstract_FL | Objective To analyze the clinical characteristics and to evaluate immunosuppressive therapy (IST) response and survival in hepatitis-associated aplastic anemia (HAAA).Methods We retrospectively analyzed clinical characteristics,IST response,long-term survival and clonal evolution in 41 HAAA patients,and compared those with age and bone marrow failure matched idiopathic aplastic anemia (IAA) patients.Results The prevalence of HAAA among cases of SAA was 4.34％ (41/944).The proportion of VSAA in HAAA cases was significantly higher than IAA (65.9％ vs 39.4％,P=0.001).There was no significant difference in the prevalence of hemorrhage and infections between HAAA and IAA patients,but the duration of infection persistence in HAAA group was much longer than IAA group [21 (4-100) d vs 13 (3-139) d,P=0.048].The absolute counts of CD3+ T-cell,CD3+CD4+T-cell,CD3+CD8+T-cell and ratio of CD4+ T-cell/CD8+ T-cell in HAAA were significant lower than that in IAA patients.However,the percentage of CD3+CD8+T-cell in HAAA was significant higher than that in IAA (P ＜0.05).The total response in HAAA and IAA patients treated with IST were 34.1％ vs 34.1％ (P=1.000),56.1％ vs 53.7％ (P=0.787),and 73.2％ vs 68.3％ (P=0.558) at 3,6,12 months after IST,respectively.There were no significant difference in 5-year overall survival and event-free survival between HAAA and IAA patients (90％ vs 87.1％,P=0.700;71.9％ vs 62.4％,P=0.450).Conclusion HAAA was a rare distinct variant of aplastic anemia with more severe bone marrow failure and more severe imbalance of the T cell immune system than IAA.Treatment outcomes were comparable in patients with HAAA and IAA. |
| Author | 杨文睿 井丽萍 周康 彭广新 李洋 叶蕾 李园 李建平 樊慧慧 宋琳 赵馨 杨洋 张凤奎 张莉 |
| AuthorAffiliation | 中国医学科学院、北京协和医学院血液学研究所、血液病医院,天津300020 |
| AuthorAffiliation_xml | – name: 中国医学科学院、北京协和医学院血液学研究所、血液病医院, 天津,300020 |
| Author_xml | – sequence: 1 fullname: 杨文睿 井丽萍 周康 彭广新 李洋 叶蕾 李园 李建平 樊慧慧 宋琳 赵馨 杨洋 张凤奎 张莉 |
| BookMark | eNo9kEtLAlEYhs_CILX-RItoM9OZc5k5LkO6gdDGTSuZOTPjhRzLIdJWNqCYoRCUQRekWrhwEZSEFfhrnEv_ohNG8ML38n4P3wdvAsScimMBsKZAGWsqXOdlXS7JRdd1ZIgolpCGNBlBRZUhlSFMxUD8P18ECdctQUjEnsTBPlFm04vIewi9Xng38ZtvfqsbXg2-b-_Dp27QGEbjUfTYCLznqNGcTcb-Zyc8__CnZ7NJz292w_4o6Fz67ffg9Svs3wgF1-1o6PkvgyWwYOsHrrX8N5Mgu7WZTe9Imb3t3fRGRuKUpSSdYooNZFhIIZqFoUE5solKsI1NzcSUaZylOFUQ58IiYmq6QQkzVYsxYhGOk2B1fvZEd2zdyedKleOqIx7mTgu1eu23BUhFBwJcmYO8UHHyR0WBHlaLZb1az6kqY4gxleIfgseBeA |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3760/cma.j.issn.0253-2727.2016.05.009 |
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | Hepatitis-associated aplastic anaemia： clinical characteristics and immunosuppressive therapy outcomes |
| DocumentTitle_FL | Hepatitis-associated aplastic anaemia: clinical characteristics and immunosuppressive therapy outcomes |
| EndPage | 404 |
| ExternalDocumentID | zhxyx201605009 668828865 |
| GroupedDBID | --- -05 2B. 2C~ 2RA 92F 92I 92L ACGFS ALMA_UNASSIGNED_HOLDINGS CCEZO CIEJG CQIGP CW9 F5P OK1 RPM TCJ TGQ U1G U5O W91 ~WA 4A8 93N ABJNI PSX |
| ID | FETCH-LOGICAL-c589-a5353b2be2147e30b5c2f4643f3d7d3587c89c512cc87c24d7ab548d6e884e4c3 |
| ISSN | 0253-2727 |
| IngestDate | Thu May 29 04:03:11 EDT 2025 Wed Feb 14 10:19:19 EST 2024 |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 5 |
| Keywords | 贫血,再生障碍性 肝炎 Hepatitis Treatment outcome Immunosuppression 治疗结果 免疫抑制法 Anemia,aplastic |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c589-a5353b2be2147e30b5c2f4643f3d7d3587c89c512cc87c24d7ab548d6e884e4c3 |
| Notes | Objective To analyze the clinical characteristics and to evaluate immunosuppressive therapy （IST） response and survival in hepatitis-associated aplastic anemia （HAAA）. Methods We retrospectively analyzed clinical characteristics, IST response, long-term survival and clonal evolution in 41 HAAA patients, and compared those with age and bone marrow failure matched idiopathic aplastic anemia （IAA） patients. Results The prevalence of HAAA among cases of SAA was 4.34% （41/944）. The proportion of VSAA in HAAA cases was significantly higher than IAA （65.9% vs 39.4%, P=-0.001 ）. There was no significant difference in the prevalence of hemorrhage and infections between HAAA and IAA patients, but the duration of infection persistence in HAAA group was much longer than IAA group [21 （4- 100） d vs 13（3-139） d, P=0.048]. The absolute counts of CD3＋T-cell, CD3＋CD4＋T-cell, CD3＋CD8＋T-cell and ratio of CD4＋ T-cell/CD8＋ T-cell in HAAA were significant lower than that in IAA patients. However, the percentage of CD3 ＋CD8＋T-cell |
| PageCount | 6 |
| ParticipantIDs | wanfang_journals_zhxyx201605009 chongqing_primary_668828865 |
| PublicationCentury | 2000 |
| PublicationDate | 2016 |
| PublicationDateYYYYMMDD | 2016-01-01 |
| PublicationDate_xml | – year: 2016 text: 2016 |
| PublicationDecade | 2010 |
| PublicationTitle | 中华血液学杂志 |
| PublicationTitleAlternate | Chinese Journal of Hematology |
| PublicationTitle_FL | Chinese Journal of Hematology |
| PublicationYear | 2016 |
| Publisher | 中国医学科学院、北京协和医学院血液学研究所、血液病医院, 天津,300020 |
| Publisher_xml | – name: 中国医学科学院、北京协和医学院血液学研究所、血液病医院, 天津,300020 |
| SSID | ssj0042014 ssib051368330 ssib017477332 ssib001103535 ssib058574913 |
| Score | 2.0527656 |
| Snippet | ... 目的 分析肝炎相关再生障性贫血(HAAA)临床特征,评价其免疫抑制治疗(IST)疗效及生存状况.方法 回顾性分析944例接受IST的重型/极重型AA(SAA/VSAA)患者,比较41例HAAA患者与年龄、造血衰竭程度相匹配的123例特发性AA(IAA)临床特征、血液学反应率、长期生存率及克隆性演变情况.结果... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 399 |
| SubjectTerms | 免疫抑制法 再生障碍性 治疗结果 肝炎 贫血 |
| Title | 41例肝炎相关再生障碍性贫血患者临床特征与免疫抑制治疗疗效观察 |
| URI | http://lib.cqvip.com/qk/93752X/201605/668828865.html https://d.wanfangdata.com.cn/periodical/zhxyx201605009 |
| Volume | 37 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxRBEB5CBPEiiooxPnKwwcvGnZnu6e7jzO4swYOnCPG0zGsTBFeNCcSc4kIkRhIQNIIPgnrIIQdBg0SF_Jrsw39hVc1kdhKDUWEZiurqr6qruqe7Z_thGFcdYaoklhG0NC5LXDWsUpA4UYmHYRQkZgJ1mk77vOmM3eI3JsTEwOB0YdXS7Ew4Gs0fuq_kf6IKPIgr7pL9h8jmoMAAGuILT4gwPP8qxtxkPmeez5THfMWUxXSV-RIJ5SOhPeYp5gumBPNsIhymSEZzpmvM10y7TFeQ41qU5ODiB1cioMeZS8iuiUxMsphrk64yYqJ2EgNkz2XKJe2aeZo4YJiZyaA9ZEam3SFkB7Nok5IAx0GOZzHPy2S0LBDwJDG0h8oIudwalKI4wM7UuVXCrJLegv0e4WPGKnNJHXgshfIAKu-UsxRXEQFmpoZUQaovwrHMOvdCFTVp8Eu1LyKwdK7K_OPJYgpkSM0Eb4HyVJFXLn6HSTeIUpvZVzCMa1rCCjkrL49E16QOzTgQYI2h9W2KmZnlQoeS_W5lz1M1QrYw9RDkHOcP3gTtZaxYSOgsnFAbUDjX_nt2icZgZcqV7umC5k_oHOEwAxACuDb9tV3owyxhlyyZHv-w1-Gmp_xkLxZR6D3t9K6sbCDG03upD_bxuIoLGmZ0Nxi9Q0pGcyW4UtOhg3jLuj--yVedzk_NPZpDkbKgPb_HLClNceALHwyHbdGfQgjTdpTdn2LD7Fpy-mc_He1xwKMj6vZsOG5cy4y8fpSJeJzL1L3m5AMYpNKewWYjaE4Whrfjp4yT2bx0xE1fMqeNgfmpM8Ztbu7uPOu13nVbq9032-3FL-0nK90X6z9fv-1-WOksbPS2NnvvFzqtj72Fxd3trfb35e7Tb-2dx7vbq-3Fle7aZmf5eXvpa-fzj-7aK_h1Xi71NlrtT-tnjfGaP14ZK2V3sZQioXQpAJfYoRUmeK1ZYpdDEVkNDrOZhh3L2BZKRkpHMHmIIiAtHssgFFzFTqIUT3hknzMGm_eayXljhEdWHEdBHDpOwBthqK1GkkgrashEAbg9ZAznXqnfT4_cqTuOUpZSjhgyrmR-qmcv4of1_XG9cKTEsHEC6fRD6kVjcGZ6NrkEU4uZ8DLVhV8zNd6w |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=41%E4%BE%8B%E8%82%9D%E7%82%8E%E7%9B%B8%E5%85%B3%E5%86%8D%E7%94%9F%E9%9A%9C%E7%A2%8D%E6%80%A7%E8%B4%AB%E8%A1%80%E6%82%A3%E8%80%85%E4%B8%B4%E5%BA%8A%E7%89%B9%E5%BE%81%E4%B8%8E%E5%85%8D%E7%96%AB%E6%8A%91%E5%88%B6%E6%B2%BB%E7%96%97%E7%96%97%E6%95%88%E8%A7%82%E5%AF%9F&rft.jtitle=%E4%B8%AD%E5%8D%8E%E8%A1%80%E6%B6%B2%E5%AD%A6%E6%9D%82%E5%BF%97&rft.au=%E6%9D%A8%E6%96%87%E7%9D%BF&rft.au=%E4%BA%95%E4%B8%BD%E8%90%8D&rft.au=%E5%91%A8%E5%BA%B7&rft.au=%E5%BD%AD%E5%B9%BF%E6%96%B0&rft.date=2016&rft.pub=%E4%B8%AD%E5%9B%BD%E5%8C%BB%E5%AD%A6%E7%A7%91%E5%AD%A6%E9%99%A2%E3%80%81%E5%8C%97%E4%BA%AC%E5%8D%8F%E5%92%8C%E5%8C%BB%E5%AD%A6%E9%99%A2%E8%A1%80%E6%B6%B2%E5%AD%A6%E7%A0%94%E7%A9%B6%E6%89%80%E3%80%81%E8%A1%80%E6%B6%B2%E7%97%85%E5%8C%BB%E9%99%A2%2C+%E5%A4%A9%E6%B4%A5%2C300020&rft.issn=0253-2727&rft.volume=37&rft.issue=5&rft.spage=399&rft.epage=404&rft_id=info:doi/10.3760%2Fcma.j.issn.0253-2727.2016.05.009&rft.externalDocID=zhxyx201605009 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F93752X%2F93752X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhxyx%2Fzhxyx.jpg |